241 related articles for article (PubMed ID: 33232271)
21. Biosynthesis of zinc oxide nanoparticles usingMangifera indica leaves and evaluation of their antioxidant and cytotoxic properties in lung cancer (A549) cells.
Rajeshkumar S; Kumar SV; Ramaiah A; Agarwal H; Lakshmi T; Roopan SM
Enzyme Microb Technol; 2018 Oct; 117():91-95. PubMed ID: 30037558
[TBL] [Abstract][Full Text] [Related]
22. Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy.
Behl A; Sarwalia P; Kumar S; Behera C; Mintoo MJ; Datta TK; Gupta PN; Chhillar AK
Mol Pharm; 2022 Jul; 19(7):2429-2440. PubMed ID: 35639628
[TBL] [Abstract][Full Text] [Related]
23. Sequence‑dependent effect of gemcitabine and cisplatin on A549 non‑small‑cell lung cancer cells.
Tang Y; Wang Y; Teng X
Mol Med Rep; 2013 Jul; 8(1):221-6. PubMed ID: 23715644
[TBL] [Abstract][Full Text] [Related]
24. Chemical and Green ZnO nanoparticles ameliorated adverse effects of cisplatin on histological structure, antioxidant defense system and neurotrophins expression in rat hippocampus.
Erfani Majd N; Tabandeh MR; Hosseinifar S; Rahimi Zarneh S
J Chem Neuroanat; 2021 Oct; 116():101990. PubMed ID: 34146667
[TBL] [Abstract][Full Text] [Related]
25. Combinational dual drug delivery system to enhance the care and treatment of gastric cancer patients.
Xiao Y; Gao Y; Li F; Deng Z
Drug Deliv; 2020 Dec; 27(1):1491-1500. PubMed ID: 33100060
[TBL] [Abstract][Full Text] [Related]
26. Enhanced anti-lung carcinoma and anti-biofilm activity of fungal molecules mediated biogenic zinc oxide nanoparticles conjugated with β-D-glucan from barley.
Saravanakumar K; Jeevithan E; Hu X; Chelliah R; Oh DH; Wang MH
J Photochem Photobiol B; 2020 Jan; 203():111728. PubMed ID: 31864088
[TBL] [Abstract][Full Text] [Related]
27. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer.
Ray P; Dutta D; Haque I; Nair G; Mohammed J; Parmer M; Kale N; Orr M; Jain P; Banerjee S; Reindl KM; Mallik S; Kambhampati S; Banerjee SK; Quadir M
Mol Pharm; 2021 Jan; 18(1):87-100. PubMed ID: 33231464
[TBL] [Abstract][Full Text] [Related]
28. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.
Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M
Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247
[TBL] [Abstract][Full Text] [Related]
29. Gemcitabine inhibits cisplatin resistance in cisplatin-resistant A549 cells by upregulating trx-interacting protein and inducing cell cycle arrest.
Cao W; Yang Q; Yuan Z; Li H; Wang W; Xiao X; Wang Z; Liang L; Zhou P; Liu J; Hu X; Zhang B
Biochem Biophys Res Commun; 2020 Apr; 524(3):549-554. PubMed ID: 32014255
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of green and chemical zinc oxide nanoparticles on testis histology, sperm parameters, oxidative stress markers and androgen production in rats treated with cisplatin.
Erfani Majd N; Hajirahimi A; Tabandeh MR; Molaei R
Cell Tissue Res; 2021 May; 384(2):561-575. PubMed ID: 33433689
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
32. Mycogenic Synthesis of Extracellular Zinc Oxide Nanoparticles from
Sumanth B; Lakshmeesha TR; Ansari MA; Alzohairy MA; Udayashankar AC; Shobha B; Niranjana SR; Srinivas C; Almatroudi A
Int J Nanomedicine; 2020; 15():8519-8536. PubMed ID: 33173290
[TBL] [Abstract][Full Text] [Related]
33. Potent effect of adenoviral vector expressing short hairpin RNA targeting ribonucleotide reductase large subunit M1 on cell viability and chemotherapeutic sensitivity to gemcitabine in non-small cell lung cancer cells.
Tokunaga Y; Liu D; Nakano J; Zhang X; Nii K; Go T; Huang CL; Yokomise H
Eur J Cancer; 2015 Nov; 51(16):2480-9. PubMed ID: 26254808
[TBL] [Abstract][Full Text] [Related]
34. Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy.
Li Y; Chen Y; Li J; Zhang Z; Huang C; Lian G; Yang K; Chen S; Lin Y; Wang L; Huang K; Zeng L
Cancer Sci; 2017 Jul; 108(7):1493-1503. PubMed ID: 28444967
[TBL] [Abstract][Full Text] [Related]
35. Cost-minimization analysis for Portugal of five doublet chemotherapy regimens from two phase III trials in the treatment of advanced non-small cell lung cancer.
Pimentel FL; Bhalla S; Laranjeira L; Guerreiro M
Lung Cancer; 2006 Jun; 52(3):365-71. PubMed ID: 16650499
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models.
Higgins B; Kolinsky K; Smith M; Beck G; Rashed M; Adames V; Linn M; Wheeldon E; Gand L; Birnboeck H; Hoffmann G
Anticancer Drugs; 2004 Jun; 15(5):503-12. PubMed ID: 15166626
[TBL] [Abstract][Full Text] [Related]
37. Enhanced cytotoxic and genotoxic effects of gadolinium-doped ZnO nanoparticles on irradiated lung cancer cells at megavoltage radiation energies.
Zangeneh M; Nedaei HA; Mozdarani H; Mahmoudzadeh A; Salimi M
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109739. PubMed ID: 31349426
[TBL] [Abstract][Full Text] [Related]
38. Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer.
Chougule MB; Patel A; Sachdeva P; Jackson T; Singh M
PLoS One; 2011; 6(11):e27394. PubMed ID: 22102891
[TBL] [Abstract][Full Text] [Related]
39. Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma.
Pattarawat P; Hong T; Wallace S; Hu Y; Donnell R; Wang TH; Tsai CL; Wang J; Wang HR
Br J Cancer; 2020 Jul; 123(2):226-239. PubMed ID: 32390005
[TBL] [Abstract][Full Text] [Related]
40. MALAT1 enhances gemcitabine resistance in non-small cell lung cancer cells by directly affecting miR-27a-5p/PBOV1 axis.
Chen W; Tan X; Yang Q; Fang Z; Xu Y
Cell Signal; 2022 Jun; 94():110326. PubMed ID: 35367362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
